Q05320 (VGP_EBOZM) Zaire ebolavirus (strain Mayinga-76) (ZEBOV) (Zaire Ebola virus)
Envelope glycoprotein UniProtKBInterProInteractive Modelling
It is possible new templates exist for this target since these models were created.
Available Structures
54 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| CRYSTAL STRUCTURE OF EBOLAVIRUS GLYCOPROTEIN IN COMPLEX WITH BEPRIDIL |
Heteromer | 99.59 | 3×NAG; 12×NAG; 15×GOL; 9×DMS; 3×CQN; | |||
| CRYSTAL STRUCTURE OF EBOLAVIRUS GLYCOPROTEIN IN COMPLEX WITH SERTRALINE |
Heteromer | 99.59 | 3×NAG; 12×NAG; 15×GOL; 3×SRE; 3×DMS; | |||
| CRYSTAL STRUCTURE OF EBOLAVIRUS GLYCOPROTEIN IN COMPLEX WITH benztropine |
Heteromer | 99.59 | 15×NAG; 15×GOL; 6×CXQ; 39×DMS; | |||
| CRYSTAL STRUCTURE OF EBOLAVIRUS GLYCOPROTEIN IN COMPLEX WITH PAROXETINE |
Heteromer | 99.59 | 3×NAG; 12×NAG; 3×DMS; 15×GOL; 3×8PR; | |||
| Crystal structure of Ebola glycoprotein in complex with ibuprofen |
Heteromer | 99.6 | 3×NAG; 12×NAG; 15×GOL; 3×IBP; | |||
| Crystal structure of Ebola glycoprotein in complex with toremifene |
Heteromer | 99.6 | 3×NAG; 12×NAG; 6×GOL; 3×DMS; 3×T0R; | |||
| Crystal structure of Ebolavirus glycoprotein in complex with inhibitor 118 |
Heteromer | 99.6 | 3×NAG; 15×NAG; 9×GOL; 6×GON; 3×DMS; | |||
| Crystal structure of Ebola glycoprotein |
Heteromer | 99.61 | 3×NAG; 15×NAG; 6×GOL; | |||
| Crystal structure of Ebolavirus glycoprotein in complex with imipramine |
Heteromer | 99.59 | 3×NAG; 12×NAG; 18×GOL; 6×IXX; 9×DMS; | |||
| Crystal structure of Ebolavirus glycoprotein in complex with inhibitor 118a |
Heteromer | 99.6 | 3×NAG; 15×NAG; 12×GOL; 6×GKZ; 3×DMS; | |||
| EM structure of a EBOV-GP bound to 3T0331 neutralizing antibody |
Heteromer | 99.59 | 3×NAG; 3×MAN; 3×NAG; | |||
| EM structure of a EBOV-GP bound to 4M0368 neutralizing antibody |
Heteromer | 99.59 | 3×NAG; 3×NAG; | |||
| Crystal Structure of Ebola zaire Envelope glycoprotein GP in complex with compound ARN0075146 |
Heteromer | 97.07 | 3×NAG; 12×NAG; 3×YOD; 6×GOL; | |||
| Crystal Structure of Ebola zaire Envelope glycoprotein GP in complex with compound ARN0075231 |
Heteromer | 99.57 | 3×NAG; 12×NAG; 3×ZQH; 3×EDO; 6×ACT; | |||
| Crystal Structure of Ebola zaire Envelope glycoprotein GP in complex with compound ARN0075093 |
Heteromer | 99.57 | 3×NAG; 12×NAG; 3×EDO; 6×ACT; 3×ZTL; | |||
| Crystal Structure of Ebola zaire Envelope glycoprotein GP in complex with compound ARN0074953 |
Heteromer | 97.46 | 3×NAG; 12×NAG; 3×YPS; | |||
| Crystal Structure of Ebola zaire Envelope glycoprotein GP in complex with compound ARN0075164 |
Heteromer | 97.48 | 3×NAG; 12×NAG; 9×EDO; 3×YPM; | |||
| Crystal structure of Ebola Zaire envelope glycoprotein GP in complex with compound ARN75092 |
Heteromer | 97.07 | 3×NAG; 12×NAG; 3×XJ5; 3×GOL; | |||
| Crystal Structure of Ebola zaire GP protein with bound ARN0074898 |
Heteromer | 99.57 | 3×NAG; 12×NAG; 15×GOL; 3×KHG; | |||
| Ebola virus glycoprotein in complex with EBOV-520 Fab |
Heteromer | 100 | 3×NAG; 3×GOL; | |||
| Structural Basis for Broad Neutralization of Ebolaviruses by an Antibody Targeting the Glycoprotein… |
Heteromer | 99.11 | 1×NAG; 2×NAG; | |||
| EBOV GP in complex with variable Fab domains of IgGs c2G4 and c13C6 |
Heteromer | 100.0 | 3×NAG; 3×NAG; 3×NAG; 3×NAG; 3×NAG; | |||
| EBOV GP in complex with variable Fab domains of IgGs c4G7 and c13C6 |
Heteromer | 100.0 | 3×NAG; 3×NAG; 3×NAG; | |||
| EBOV GP/Nanosota-EB1 |
Heteromer | 100.0 | 1×NAG; 1×NAG; 1×NAG; | |||
| EBOV GP/Nanosota-EB2 complex |
Heteromer | 100.0 | 1×NAG; 1×NAG; 1×NAG; 1×MAN; | |||
| Structure of the Inmazeb cocktail and resistance to escape against Ebola virus |
Heteromer | 100.0 | 3×NAG; 8×NAG; | |||
| Structure of EBOV GPcl in complex with the pan-ebolavirus mAb ADI-15878 |
Heteromer | 100 | 1×NAG; 2×NAG; 1×NAG; 2×NAG; | |||
| Structure of ZEBOV GP in complex with 1T0227 antibody |
Heteromer | 99.46 | 3×NAG; | |||
| Structure of ZEBOV GP in complex with 3T0265 antibody |
Heteromer | 99.46 | 3×NAG; | |||
| BDBV-289 bound to EBOV GPdMuc Makona |
Heteromer | 99.15 | 3×NAG; 9×NAG; | |||
| Structure of ZEBOV GP in complex with 5T0180 antibody |
Heteromer | 99.46 | 3×NAG; | |||
| Cleaved Ebola GP in complex with a broadly neutralizing human antibody, ADI-15946 |
Heteromer | 100 | 2×NAG; 1×NAG; | |||
| Crystal structure of the trimeric prefusion Ebola virus glycoprotein in complex with a neutralizing… |
Heteromer | 99.15 | 2×NAG; 2×NAG; 1×NAG; 1×NAG; | |||
| Crystal Structure of Protective Human Antibodies 100 and 114 in Complex with Ebola Virus Fusion Gly… |
Heteromer | 100 | ||||
| Structure of EBOV GP lacking the mucin-like domain with 1C11 scFv and 1C3 Fab bound |
Heteromer | 100.0 | 3×NAG; | |||
| EBOV GP bound to rEBOV-442 and rEBOV-515 Fabs |
Heteromer | 99.1 | 6×NAG; 3×NAG; 6×NAG; | |||
| Ebola virus GP (mucin deleted, Makona strain) bound to antibody Fab EBOV-293 |
Heteromer | 99.09 | 3×NAG; 3×NAG; 6×NAG; | |||
| Ebola virus GP (mucin deleted, Makona strain) bound to antibody Fab EBOV-296 and EBOV-515 |
Heteromer | 99.09 | 3×NAG; 9×NAG; | |||
| Ebola virus GP (mucin deleted, Makona strain) bound to antibody Fab EBOV-442 |
Heteromer | 99.1 | 6×NAG; 3×NAG; 6×NAG; | |||
| Ebola virus GP (mucin deleted, Makona strain) bound to antibody Fab EBOV-437 |
Heteromer | 99.13 | 3×NAG; 3×NAG; 9×NAG; | |||
| Structure of EBOV GP lacking the mucin-like domain with 2.1.1D5 scFv and 6D6 scFv bound |
Heteromer | 100.0 | 3×NAG; 3×NAG; | |||
| Structure of EBOV GP lacking the mucin-like domain with 9.20.1A2 Fab and 6D6 scFv bound |
Heteromer | 100.0 | 3×NAG; 3×NAG; | |||
| EBOV sGP in complex with variable Fab domains of IgGs c13C6 and BDBV91 |
Heteromer | 100 | ||||
| Crystal structure of host-primed Ebola virus GP, GPcl. |
Heteromer P87666; | 100 | 3×NAG; | |||
| Crystal structure of EBOV glycoprotein with modified HR1c and HR2 stalk at 3.2 A resolution | homo-6-mer | 99.61 | 3×NAG; 3×NAG; 6×NAG; 3×PO4; | |||
| Crystal structure of Ebolavirus glycoprotein in complex with clomipramine | homo-6-mer | 99.59 | 3×NAG; 12×NAG; 12×GOL; 3×CXX; | |||
| Crystal structure of Ebolavirus glycoprotein in complex with thioridazine | homo-6-mer | 99.59 | 3×NAG; 12×NAG; 12×GOL; 9×DMS; 3×RTZ; | |||
| Crystal structure of EBOV glycoprotein with modified HR2 stalk at 2.3A resolution | homo-6-mer | 99.59 | 6×NAG; 3×NAG; 6×GOL; 3×NAG; 3×PO4; | |||
| Crystal Structure of Stabilized GP from Makona Variant of Ebola Virus | homo-3-mer | 98.72 | 3×NAG; 3×NAG; | |||
| CORE STRUCTURE OF GP2 FROM EBOLA VIRUS | homo-3-mer | 98.65 | 1×CL; | |||
| NMR Structure of the Complete Internal Fusion Loop mutant L529A/I544A from Ebolavirus GP2 at pH 5.5 | monomer | 96.3 | ||||
| NMR Structure of the Complete Internal Fusion Loop from Ebolavirus GP2 at pH 5.5 | monomer | 100 | ||||
| NMR Structure of the Complete Internal Fusion Loop from Ebolavirus GP2 at pH 7.0 | monomer | 100 | ||||
| NMR Structure of Ebola fusion peptide in SDS micelles at pH 7 | monomer | 100 | ||||
1 SWISS-MODEL model
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 6vkm.1.C | homo-3-mer | 0.56 | 2×NAG; | 98.36 | ||